Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?

Author： Giachini Fernanda RC   Callera Glaucia E   Carneiro Fernando S   Tostes Rita C   Webb R Clinton  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.12, Iss.3, 2008-03, pp. : 327-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential therapeutic targets for neurokinin-1 receptor antagonists

By Duffy Ruth A  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

Pathophysiologic therapeutic targets in hypertension: a cardiological point of view

By Fragasso Gabriele   Maranta Francesco   Montanaro Claudia   Salerno Anna   Torlasco Camilla   Margonato Alberto  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 2, 2012-02 ,pp. : 179-193

Informa Healthcare

Access to resources Recommend Favorite

Pulmonary Hypertension in COPD: Pathophysiology and Therapeutic Targets

By  

Current Drug Targets, Vol. 12, Iss. 4, 2011-04 ,pp. : 501-513

Bentham Science Publishers

Access to resources Recommend Favorite

TRP Channels as Therapeutic Targets in Kidney Disease and Hypertension

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 3, 2013-02 ,pp. : 386-397

Bentham Science Publishers

Access to resources Recommend Favorite

Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: Rationale and Place in Therapy

By Price Laura C.   Howard Luke S.G.E.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite